FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US

Disclosure: M. Hoog: Employee; Self; Eli Lilly & Company. Stock Owner; Self; Eli Lilly & Company. J. Maldonado: Employee; Self; Eli Lilly & Company. Stock Owner; Self; Eli Lilly & Company. R. Wangia-Dixon: Employee; Self; Optum Inc. Other; Self; Eli Lilly & Company. R. Halpern: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoog, Meredith, Maldonado, Juan, Wangia-Dixon, Ruth, Halpern, Rachel, Buysman, Erin, Gremel, Garrett, Huang, Ahong, Konig, Manige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555009/
http://dx.doi.org/10.1210/jendso/bvad114.857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555009/
http://dx.doi.org/10.1210/jendso/bvad114.857

Ejemplares similares